Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
09:56
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

13th International Conference on Malignant Lymphoma

 

17-20 June 2015 Lugano
FAQs
   
Discussion forum - 13th International Conference on Malignant Lymphoma
    Topic - Ongoing trials

If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER.
 

Poster: 286
Visits: 87
Title: Phase I dose-escalation study of BI 836826 in patients (pts) with relapsed or refractory non-Hodgkin lymphoma (NHL) of B cell origin
Authors: Frank Kroschinsky ,
Centre: Universittsklinikum Carl Gustav Carus an der Technischen Universitt Dresden

You must be registered to reply or comment.

PHASE I DOSE-ESCALATION STUDY OF BI 836826 IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY NON-HODGKIN LYMPHOMA (NHL) OF B CELL ORIGIN

Frank Kroschinsky
Thread initiator
Subspeciality
Reg: 6/8/2015 6:17:00 PM
Comment# 1
I invite healthcare professionals to open debate around the issues raised in my poster, both those relating to research and to clinical practice.

Comment added on 6/8/2015 6:17:00 PM 
     
You must be registered to reply or comment.



Most viewed poster for this congress
Poster: 9
Visits: 649
Title: Ibrutinib in combination with Rituximab for Relapsed Mantle Cell Lymphoma: An Update from a Phase II Clinical Trial
Authors: Michael Wang ,
Centre: The University of Texas MD Anderson Cancer Center

Poster most viewed in this topic
Poster: 14
Visits: 271
Title: CLLR3 A randomized Phase II trial evaluating the chemotherapies FC/ B combined with GA101 followed by GA101 maintenance in relapsed/ refractory CLL
Authors: Nadine Kutsch ,
Centre: University Hospital of Cologne


 




PosterSessionOnline
Logo Draft
 
Logo Cert